The hospital plans to scale up its number of healthcare centres to 600 and enrol 2 lakh patients per annum by 2025
‘Madhavbaug Cardiac Care Center and Hospitals’- the flagship brand of NSE listed Vaidya Sane Ayurved Laboratories, a specialist in treating and reversing cardiac-related ailments got NABH accreditation for its state-of-the-art hospital located at Khopoli, Maharashtra.
The NABH accreditation came as a shot in the arm for Madhavbaug, which has planned major expansion across India and put Indian Ayurveda on the global map through its evidence-based scientific Ayurveda. The company, which reported a 785 per cent growth in profit after tax (PAT) at Rs3.46 crore in FY22, plans to scale up its number of healthcare centres to 600 and enrol 2 lakh patients per annum by 2025 as compared to a footfall of 80k-90k patients per annum witnessed at its 270 centres currently.
“I would like to reiterate our focus on quality patient care, innovation and continued pursuit of medical excellence. In this regard, we will continue to build upon our team of exceptionally committed Doctors, and other support staff to deliver world-class patient care services. We will also continue to provide a safe environment for patients and employees alike,” said Dr Rohit Sane, Founder, MD and CEO, Madhavbaug.
